Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.
Clicks: 377
ID: 80136
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.3
/100
11 views
11 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
jubbincidenceantiviral
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jubb, Becky;Lewis, Marilyn;McFadyen, Lynn;Simpson, Paul;Mori, Julie;Chan, Phylinda;Weatherley, Barry;van der Ryst, Elna;Westby, Mike;Craig, Charles; |
| Journal | antiviral chemistry & chemotherapy |
| Year | Year not found |
| DOI |
10.1177/2040206619895706
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.